✦ LIBER ✦

3–49 Adjuvant Docetaxel or Vinorelbine With or Without Trastuzumab for Breast Cancer

✍ Scribed by Tripathy, D.

Book ID: 123166319
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 147 KB
Volume: 17
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(06)80537-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab plus vinorelbine or taxane c

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study

✍ Harold J. Burstein; Aparna Keshaviah; Ari D. Baron; Ronald D. Hart; Rosemary Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

## Abstract ## BACKGROUND. The optimal trastuzumab‐based chemotherapy regimen for HER2‐overexpressing, metastatic breast cancer is not known. The __tr__astuzumab __a__nd __vi__norelbine __o__r __ta__xane (TRAVIOTA) study was a prospective, multicenter, randomized trial that was designed to compare

Trastuzumab with either docetaxel or vin

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

✍ Stefania Redana; Michela Donadio; Franco Nolè; Maria Elena Jacomuzzi; Alessandra 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 309 KB

Management and Outcome of HER2-Positive

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Incidence of reversible amenorrhea in wo

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel

✍ Martine Berliere; Florence Dalenc; Nathalie Malingret; Anita Vindevogel; Philipp 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 433 KB

Incidence of Heart Failure or Cardiomyop

Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

✍ Chen, Jersey; Long, Jessica B.; Hurria, Arti; Owusu, Cynthia; Steingart, Richard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Phase II Multicenter Study of Docetaxel

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB